Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/baricitinib-misses-key-safety-benchmark-blood-clots-and-2026a1000iyi?src=rss
Author :
Publish date : 2026-06-06 20:49:00
Copyright for syndicated content belongs to the linked Source.